RxDoctor Payments Data

Jack Keller

Family Medicine · Marion, ILNPI 1467636605

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,518 and has fallen 93.1% since, to $173 in 2022. Among family medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,338in general payments, 2019–2025

Across 358 payments — averaging $12.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$532
  • Novo Nordisk$527
  • Lilly USA, LLC$523
  • AstraZeneca$414
  • Boehringer Ingelheim$338
  • Amarin Pharma, Inc.$298
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,333100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,338 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois →

Other family medicine in Marion

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →